Author Correction: Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer

Correction to: Scientific Reports 10.1038/s41598-018-23848-8, published online 04 April 2018

This Article contains errors in the Results section.

“The median stage-adjusted survival time was 7.9 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).”

should read:

“The median stage-adjusted survival time was 7.1 months longer in patients with the highest levels of TRAIL compared to those with the lowest levels (Table 2).”

In addition, this Article contains errors in Table 1, where the reported numbers of patients under the ‘Regular Aspirin use’ subheading are incorrect. The correct totals for ‘No’ are 32 (100.0) and 97 (96.0) under Early-stage and Late-Stage respectively, and for ‘Yes’ the correct totals are 0 (0.0) and 4(4.0) respectively.